CA Stock MarketDetailed Quotes
NAV Navco Pharmaceuticals Inc
- 0.025
- +0.005+25.00%
15min DelayMarket Closed Nov 12 16:00 ET
1.43MMarket Cap-1250P/E (TTM)
0.025High0.025Low26.00KVolume0.025Open0.020Pre Close650.00Turnover0.11552wk High0.07%Turnover Ratio57.07MShares0.01552wk Low-0.02EPS TTM950.79KFloat Cap0.450Historical HighLossP/E (Static)38.03MShs Float0.015Historical Low-0.03EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
About Navco Pharmaceuticals Inc Company
Navco Pharmaceuticals Inc uses nanotechnology to develop and commercialize novel products to protect against viruses, bacteria, and infectious diseases. Its products have applications in the medical, personal care products, textile, chemical, and additive industries which are tailored to defend against microorganisms such as viruses, bacteria, fungi, and infectious diseases.
Company Profile
SymbolNAV
Company NameNavco Pharmaceuticals Inc
Founded2018
MarketTSX
Fiscal Year Ends09-30
Address1055 West Georgia Street Suite 1500
CityVancouver
CountryCAN
Zip CodeV6E 4N7
Phone+1 604 307-8290
Websitehttps://www.navcopharma.com
Company Executives
- Name
- Position
- Salary
- Christopher R. Cooper
- Chief Financial Officer
- --
- Marek Jasinski
- Chief Operating Officer and Director
- --
- Jatinder Dhaliwal
- Independent Director
- --
- Judy Su
- Independent Director
- --
- Thomas Jusdanis
- Independent Director and Corporate Secretary
- --
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data